13 aa
Predicted · Cα pLDDT 94.5 / 100
Completion observed (Asia/Shanghai):
Static model
PAE · Å
PAE image is unavailable.
pTM 0.03
A few molecular notes beside a poem.
WEREADTHEGAPS
These model readings are not real-world event rates; suitability for this peptide has not been validated.
Modelled molecular behavior
Each endpoint keeps its own 0–1 model output; these are not cross-endpoint rankings.
Absorption & transport
- Intestinal absorption · HIA
- 0.12
- Oral bioavailability
- 0.35
- Blood–brain barrier · BBB
- 0.20
- P-gp
- 0.39
Metabolism · CYP
Safety-related assays
- Ames assay
- 0.18
- Drug-induced liver injury · DILI
- 0.53
- hERG channel
- 0.61
Reading notes & six additional results
Classification outputs are uncalibrated; they do not establish individual event probabilities or safety.
Method: TabPFN2.5 · tdc22_v1
Chemical form: linear L-peptide, with free, neutral termini and side chains.
Units and numerical scales for these six endpoints remain unconfirmed; the model readings are retained below.
- Caco-2
- -6.98
- Hepatocyte clearance
- 26.68
- Microsomal clearance
- 53.16
- Half-life
- 12.29
- Plasma protein binding
- 57.97
- Distribution volume
- 0.34
Readings retain the scale returned for each endpoint; no conversion to linear physical quantities has been made. Glyphs identify endpoints, not measurement axes.